Large-Scale Counterfeit Pill Manufacturer Charged With Drug Offenses And Pandemic Loan Fraud
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Large-Scale Counterfeit Pill Manufacturer Charged With Drug Offenses And Pandemic Loan Fraud

Large-Scale Counterfeit Pill Manufacturer Charged With Drug Offenses And Pandemic Loan Fraud

July 23, 2024
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kristen Govostes
Phone Number: (617) 557-2100

Defendant Allegedly Sought to Import Kilograms of Fentanyl Precursor Chemicals into the United States and Synthesize Fentanyl

BOSTON – A Cambridge man was arrested on July 18th in connection with an ongoing investigation of counterfeit pills containing fentanyl and methamphetamine. Over the course of the past four years, the defendant is alleged to have been responsible for the manufacturing of over 200 kilograms of counterfeit pills.

Schuyler Oppenheimer, a/k/a “SK,” a/k/a “Michael Sylvain,” 33, of Cambridge was charged with possession of 500 grams and more of a mixture and substance containing a detectable amount of methamphetamine and two counts of wire fraud. The defendant appeared in U.S. District Court and was detained pending further court hearings.  

“Fentanyl and methamphetamine being distributed in the form of fake pills is causing tremendous damage to our community,” said Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration, New England Field Division. “Those who distribute these drugs are endangering the safety of the citizens of the Massachusetts. The DEA will continue to work each day alongside our law enforcement partners to identify those who are responsible for distributing deadly drugs.”

“The sprawling manufacturing of illegal drugs alleged in this case is as dangerous as it is appalling. It is alleged that Mr. Oppenheimer illegally manufactured hundreds of kilograms of lethal drugs in order to continue to saturate our streets with deadly drugs,” said Acting United States Attorney Joshua S. Levy. “Our office is dedicated to stopping the flow of fentanyl into our communities, which, as evidenced by these charges, includes shipments from China. This case is yet another example of the critical collaboration between federal law enforcement partners and the Massachusetts State Police to prevent illegal narcotics from reaching our streets.”

“The FBI’s North Shore Gang Task Force has arrested Schuyler Oppenheimer – an alleged large-scale counterfeit pill manufacturer – who’s accused of producing a massive number of pills that looked like regular prescription Adderall or Percocet, but in reality, contained methamphetamine or fentanyl. Each alleged sale was a potentially deadly transaction for customers – or anyone else who stumbled upon these deceptive drugs,” said Jodi Cohen, Special Agent in Charge of the Federal Bureau of Investigation, Boston Division. “Drug dealers making money off the misery of others is bad enough, let alone this dangerous bait and switch. Taking Oppenheimer off the street should send a message that the FBI and our law enforcement partners will not cede our cities to drug manufacturers, traffickers, and other violent criminals. We’re working hard every day to make our communities safer.”

“The defendant is accused of crimes that reflect his alleged disregard for the public's safety and wellbeing. He allegedly spearheaded a clandestine lab operation that included evidence of fentanyl precursors, and bore the potential to destroy countless lives,” said Michael J. Krol, Special Agent in Charge of Homeland Security Investigations in New England. “HSI New England is proud to stand alongside our law enforcement partners at the state, local, federal levels in confronting the deadly drug epidemic directly and forcefully.”

“Oppenheimer’s sophisticated operation has shown the utter disregard for the people in our communities.” said John Mawn, Colonel of the Massachusetts State Police. “I applaud the tireless work by the members of the MSP and our Law Enforcement partners assigned to the Task Force. Oppenheimer’s arrest will hopefully make a significant impact to the affected communities and stop the destruction of lives.” 

Oppenheimer is alleged to be technically skilled in the chemical processes used in the synthesis of fentanyl, the compounding of controlled substances for distribution, and the manufacturing of counterfeit pills. As alleged in court documents, recipes, pill press molds used in the manufacturing process, documents and invoices demonstrating that Oppenheimer purchased numerous pill presses and parts for pill presses from online vendors were seized. It also alleged multiple packages shipped from China to Oppenheimer and various female associates of Oppenheimer that contained pill press parts, were also seized.

According to court documents, through the review of orders and invoices from companies selling powders and other substances used in the pill manufacturing process, it is alleged that since 2019, Oppenheimer obtained over 200 kilograms of these filler powders. According to the recipes recovered during the investigation, when manufactured into counterfeit pills, 200 kilograms of filler powder equates to millions of counterfeit pills containing fentanyl and methamphetamine.

Additionally, Oppenheimer is alleged to have communicated directly with an illegal chemical supplier based in China. During this conversation, Oppenheimer allegedly inquired about the availability of controlled substances and fentanyl precursor chemicals and sought to purchase kilogram quantities of these substances. Fentanyl precursor chemicals are substances that can be used to synthesize raw fentanyl in a laboratory setting. It is alleged that Oppenheimer sought to synthesize his own fentanyl through the importation of these fentanyl precursor chemicals. 

Oppenheimer is also alleged to have obtained over $40,000 through two fraudulent Paycheck Protection Program loan applications that were submitted in April 2021 over the internet. Oppenheimer is also alleged to have submitted false statements concerning his income through self-employment for the 2019 tax years and provided false tax return documents substantiating that income. 

During the execution of a search warrant on Parker Street in Cambridge, over five kilograms of suspected counterfeit Adderall pills containing methamphetamine and a loaded firearm were seized. Based on prior felony convictions, Oppenheimer is prohibited from possessing firearms.

The charge of possession with intent to distribute 500 grams or more of methamphetamine provides for a sentence of at least ten years and up to life in prison, five years and up to life of supervised release and a fine of up to $10,000,000. The charge of wire fraud provided for a maximum penalty of up to 20 years, up to three years of supervised release and a fine of up to $250,000. Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.

Acting US Attorney Levy; FBI SAC Cohen; DEA Acting SAC Belleau; HSI SAC Krol; Jennifer B. De La O, Director of Field Operations, U.S. Customs and Border Protection; and Interim Colonel Mawn, Jr of the Massachusetts State Police made the announcement. Valuable assistance was provided by the Cambridge Police Department. Assistant U.S. Attorney Philip A. Mallard of the Organized Crime and Gang Unit is prosecuting the case.

The details contained in the charging documents are allegations. The defendant is presumed innocent unless and until proven guilty beyond a reasonable doubt in a court of law.

Download Press Release
###
Fentanyl Methamphetamine
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Stephen Belleau, Acting Special Agent in Charge - New England
@DEANewEngland
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español